AnaConDa Long Term Sedation Study

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

February 28, 2018

Study Completion Date

November 30, 2020

Conditions
Intubated Requiring Sedation for Greater Than 48 Hours
Interventions
DRUG

Isoflurane

DRUG

Propofol/midazolam

Trial Locations (2)

K1Y 4W7

Ottawa Heart Institute, Ottawa

M5G 2C4

Toronto General Hospital, University Health Network, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT01983800 - AnaConDa Long Term Sedation Study | Biotech Hunter | Biotech Hunter